Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Marriott International Inc (MAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Marriott International Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B), while Marriott International Inc trades at $375.18 (market cap $96.87B). The key difference: Marriott International Inc is far larger — about 13.8× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Marriott International Inc pays a 0.79% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Marriott International Inc for 164 Days on average.
| IONS | MAR | |
|---|---|---|
Market Cap | $7.04B | $96.87B |
Volume | 2,977,440 | 755,878 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $402.54 |
52-Week Low | $42.38 | $259.04 |
Typical Hold Time | 0 Days | 164 Days |
Enterprise Value | $6.60B | $114.19B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Marriott International (MAR) trades at $371.50, up 0.6% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company reported revenue of $26.19B in 2025, with net income of $2.60B, though it missed Q4 2025 EPS estimates. Valuation ratios like P/E of 38.46 and P/S of 3.71 indicate a premium, while debt levels have risen to 58.83% of assets in 2025. Recent news highlights partnerships and dividend declarations, reinforcing its travel sector resilience.
The stock offers growth potential from sustained travel demand and strategic expansions, but faces risks from high leverage and economic sensitivity. Analysts are mostly neutral with a consensus price target of $388.93, suggesting modest upside. Investors should weigh solid profitability against valuation concerns and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →
